ZBTB44
gene geneOn this page
Also known as HSPC063ZNF851
Summary
ZBTB44 (zinc finger and BTB domain containing 44, HGNC:25001) is a protein-coding gene on chromosome 11q24.3, encoding Zinc finger and BTB domain-containing protein 44 (Q8NCP5). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be located in nucleus.
Source: NCBI Gene 29068 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 59 total — 1 pathogenic
- Druggable target: yes
- MANE Select transcript:
NM_001301098
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25001 |
| Approved symbol | ZBTB44 |
| Name | zinc finger and BTB domain containing 44 |
| Location | 11q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC063, ZNF851 |
| Ensembl gene | ENSG00000196323 |
| Ensembl biotype | protein_coding |
| Entrez | 29068 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000357899, ENST00000397753, ENST00000445008, ENST00000525623, ENST00000525842, ENST00000527478, ENST00000528448, ENST00000529348, ENST00000529982, ENST00000530205, ENST00000884638, ENST00000962913, ENST00000962914, ENST00000962915
RefSeq mRNA: 8 — MANE Select: NM_001301098
NM_001301098, NM_001301099, NM_001370219, NM_001370220, NM_001370221, NM_001370222, NM_001370223, NM_014155
CCDS: CCDS44776, CCDS73414, CCDS73415, CCDS91625
Canonical transcript exons
ENST00000357899 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001126571 | 130239812 | 130239896 |
| ENSE00001195601 | 130236793 | 130237093 |
| ENSE00001277720 | 130238444 | 130238607 |
| ENSE00001382564 | 130260856 | 130261929 |
| ENSE00002155538 | 130314375 | 130314917 |
| ENSE00002156880 | 130226677 | 130231715 |
| ENSE00003633271 | 130234156 | 130234273 |
| ENSE00003646415 | 130233308 | 130233382 |
Expression profiles
Bgee: expression breadth ubiquitous, 268 present calls, max score 98.76.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.7291 / max 248.3128, expressed in 1791 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 123170 | 14.9766 | 1770 |
| 123165 | 2.1385 | 954 |
| 123169 | 1.0981 | 625 |
| 123168 | 0.9292 | 543 |
| 123164 | 0.8007 | 460 |
| 123167 | 0.3820 | 202 |
| 123171 | 0.3051 | 133 |
| 123166 | 0.0989 | 36 |
Top tissues by expression
287 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.76 | gold quality |
| renal medulla | UBERON:0000362 | 98.35 | gold quality |
| biceps brachii | UBERON:0001507 | 98.10 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 97.91 | gold quality |
| caput epididymis | UBERON:0004358 | 97.87 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.86 | gold quality |
| mammary duct | UBERON:0001765 | 97.56 | gold quality |
| corpus epididymis | UBERON:0004359 | 97.20 | gold quality |
| nipple | UBERON:0002030 | 97.19 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 97.15 | gold quality |
| cerebellar vermis | UBERON:0004720 | 97.10 | gold quality |
| parietal pleura | UBERON:0002400 | 96.88 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 96.58 | gold quality |
| visceral pleura | UBERON:0002401 | 96.45 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 96.45 | gold quality |
| seminal vesicle | UBERON:0000998 | 96.20 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 96.16 | gold quality |
| bronchial epithelial cell | CL:0002328 | 96.08 | gold quality |
| superior surface of tongue | UBERON:0007371 | 96.07 | gold quality |
| upper leg skin | UBERON:0004262 | 96.04 | gold quality |
| penis | UBERON:0000989 | 95.88 | gold quality |
| urethra | UBERON:0000057 | 95.63 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 95.50 | gold quality |
| gingival epithelium | UBERON:0001949 | 95.47 | gold quality |
| jejunum | UBERON:0002115 | 95.45 | gold quality |
| body of tongue | UBERON:0011876 | 95.39 | gold quality |
| globus pallidus | UBERON:0001875 | 95.34 | gold quality |
| medial globus pallidus | UBERON:0002477 | 95.21 | gold quality |
| postcentral gyrus | UBERON:0002581 | 95.20 | gold quality |
| tibia | UBERON:0000979 | 95.19 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.15 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| CDKN2A |
miRNA regulators (miRDB)
375 targeting ZBTB44, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb44 | ENSDARG00000061110 |
| mus_musculus | Zbtb44 | ENSMUSG00000047412 |
| rattus_norvegicus | Zbtb44 | ENSRNOG00000005578 |
| drosophila_melanogaster | Opbp | FBGN0050443 |
Paralogs (2): ZNF618 (ENSG00000157657), FIZ1 (ENSG00000179943)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 44 — Q8NCP5 (reviewed: Q8NCP5)
Alternative names: BTB/POZ domain-containing protein 15, Zinc finger protein 851
All UniProt accessions (5): A0A0A0MTE9, Q8NCP5, H0YCZ0, H0YEM9, H7BY22
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NCP5-1 | 1 | yes |
| Q8NCP5-2 | 2 | |
| Q8NCP5-3 | 3 | |
| Q8NCP5-4 | 4 |
RefSeq proteins (8): NP_001288027, NP_001288028, NP_001357148, NP_001357149, NP_001357150, NP_001357151, NP_001357152, NP_054874 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF00651
UniProt features (27 total): modified residue 7, zinc finger region 4, splice variant 4, compositionally biased region 3, region of interest 3, cross-link 2, chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NCP5-F1 | 55.17 | 0.08 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (9): 135, 159, 161, 165, 191, 194, 200, 4, 290
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 224 (showing top):
GCACCTT_MIR18A_MIR18B, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, AAGCCAT_MIR135A_MIR135B, TACAATC_MIR508, CACCAGC_MIR138, TATCTGG_MIR488, TTGGAGA_MIR5155P_MIR519E, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, ZHANG_BREAST_CANCER_PROGENITORS_UP, CUI_TCF21_TARGETS_2_DN, CTGAGCC_MIR24, chr11q24, GABRIELY_MIR21_TARGETS, BRCA1_DN.V1_DN, IL15_UP.V1_DN
GO Biological Process (0):
GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
722 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB44 | MRPS14 | O60783 | 539 |
| ZBTB44 | ZSWIM8 | A7E2V4 | 528 |
| ZBTB44 | NBEAL1 | Q6ZS30 | 472 |
| ZBTB44 | TAF9B | Q9HBM6 | 456 |
| ZBTB44 | BMS1 | Q14692 | 454 |
| ZBTB44 | DDX52 | Q9Y2R4 | 453 |
| ZBTB44 | SMURF2 | Q9HAU4 | 442 |
| ZBTB44 | SLC39A13 | Q96H72 | 427 |
| ZBTB44 | SERTAD4 | Q9NUC0 | 424 |
| ZBTB44 | ZER1 | Q7Z7L7 | 420 |
| ZBTB44 | CLEC17A | Q6ZS10 | 417 |
| ZBTB44 | SLC15A2 | Q16348 | 416 |
| ZBTB44 | SACS | Q9NZJ4 | 400 |
| ZBTB44 | ECM1 | Q16610 | 393 |
| ZBTB44 | RHOBTB3 | O94955 | 386 |
IntAct
44 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMYD1 | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZBTB44 | SMYD1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZBTB44 | GLRX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAD23A | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | PSMA6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | FAM124A | psi-mi:“MI:0915”(physical association) | 0.560 |
| WDFY3 | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | AP1M1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLI | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | RAD23A | psi-mi:“MI:0915”(physical association) | 0.560 |
| PSMA6 | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | WDFY3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB44 | POLI | psi-mi:“MI:0915”(physical association) | 0.560 |
| PSG9 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| CAMK1G | RFWD3 | psi-mi:“MI:0914”(association) | 0.530 |
| ZBTB44 | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.370 |
| APBA3 | ZBTB44 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (84): ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), ZBTB44 (Two-hybrid), SMYD1 (Two-hybrid), FAM124A (Two-hybrid), ZBTB44 (Affinity Capture-MS), ZBTB44 (Affinity Capture-MS), UBA3 (Affinity Capture-MS), MYH14 (Affinity Capture-MS), USP7 (Affinity Capture-MS), SCRIB (Affinity Capture-MS)
ESM2 similar proteins: A0A1D5NS60, A0JN76, A1YFX5, A2T7G6, A6NJL1, D2HQI1, F1MJR8, O14901, P0CG00, P10754, P22227, P98182, Q0IJ29, Q1L8W0, Q3SWU4, Q5DW34, Q5EAC5, Q5EXX3, Q5RHB5, Q5SXI5, Q5T619, Q66H04, Q6NRM8, Q6NV66, Q6ZSB9, Q7M6U3, Q7TS63, Q7TSH3, Q7ZWZ4, Q801P1, Q86VK4, Q8BKX7, Q8BXX2, Q8NAM6, Q8NAP3, Q8NCP5, Q8R0A2, Q91VW9, Q96IT1, Q96N77
Diamond homologs: A0A2R8Q1W5, A9JRD8, B0WWP2, B3DIV9, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, D3ZUU2, E0CZ16, E1B932, E7F6F9, E9Q4F2, F1LZ52, F1LZF0, F1MBP6, G3X9X1, O15062, O93567, O94889, O95198, P28575, P57790, Q04652, Q08DK3, Q13105, Q14145, Q16RL8, Q1ECZ2, Q2M0J9, Q2TBA0, Q3SWU4, Q3ZB90
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 815477 | GRCh37/hg19 11q24.2-25(chr11:124232608-134938470)x1 | Pathogenic |
SpliceAI
1740 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:130233306:A:AC | donor_gain | 1.0000 |
| 11:130233307:C:CC | donor_gain | 1.0000 |
| 11:130233997:A:AC | donor_gain | 1.0000 |
| 11:130233998:A:C | donor_gain | 1.0000 |
| 11:130236763:T:TA | donor_gain | 1.0000 |
| 11:130236787:CCTCA:C | donor_loss | 1.0000 |
| 11:130236788:CTCAC:C | donor_loss | 1.0000 |
| 11:130236789:TCA:T | donor_loss | 1.0000 |
| 11:130236790:CAC:C | donor_loss | 1.0000 |
| 11:130236791:A:C | donor_loss | 1.0000 |
| 11:130236792:CCTG:C | donor_gain | 1.0000 |
| 11:130237089:AATTC:A | acceptor_gain | 1.0000 |
| 11:130237090:ATTC:A | acceptor_gain | 1.0000 |
| 11:130237091:TTC:T | acceptor_gain | 1.0000 |
| 11:130237092:TC:T | acceptor_gain | 1.0000 |
| 11:130237093:CC:C | acceptor_gain | 1.0000 |
| 11:130237094:C:CC | acceptor_gain | 1.0000 |
| 11:130237094:C:CG | acceptor_loss | 1.0000 |
| 11:130237095:T:C | acceptor_loss | 1.0000 |
| 11:130238442:A:AG | donor_loss | 1.0000 |
| 11:130238443:CCTG:C | donor_loss | 1.0000 |
| 11:130239806:A:AC | donor_gain | 1.0000 |
| 11:130239807:C:CC | donor_gain | 1.0000 |
| 11:130239808:TGA:T | donor_loss | 1.0000 |
| 11:130239809:GA:G | donor_loss | 1.0000 |
| 11:130239810:A:AC | donor_gain | 1.0000 |
| 11:130239810:ACCGA:A | donor_loss | 1.0000 |
| 11:130239811:C:CC | donor_gain | 1.0000 |
| 11:130239811:C:CG | donor_loss | 1.0000 |
| 11:130239897:C:CC | acceptor_gain | 1.0000 |
AlphaMissense
3767 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:130236873:G:C | F496L | 1.000 |
| 11:130236873:G:T | F496L | 1.000 |
| 11:130236874:A:G | F496S | 1.000 |
| 11:130236875:A:G | F496L | 1.000 |
| 11:130237053:G:C | F436L | 1.000 |
| 11:130237053:G:T | F436L | 1.000 |
| 11:130237054:A:G | F436S | 1.000 |
| 11:130237055:A:G | F436L | 1.000 |
| 11:130238470:A:G | L414P | 1.000 |
| 11:130238487:G:C | F408L | 1.000 |
| 11:130238487:G:T | F408L | 1.000 |
| 11:130238488:A:G | F408S | 1.000 |
| 11:130238489:A:G | F408L | 1.000 |
| 11:130238508:A:C | C401W | 1.000 |
| 11:130238509:C:G | C401S | 1.000 |
| 11:130238510:A:G | C401R | 1.000 |
| 11:130238510:A:T | C401S | 1.000 |
| 11:130236874:A:C | F496C | 0.999 |
| 11:130236969:G:C | F464L | 0.999 |
| 11:130236969:G:T | F464L | 0.999 |
| 11:130236971:A:G | F464L | 0.999 |
| 11:130236992:A:G | C457R | 0.999 |
| 11:130237028:G:C | H445D | 0.999 |
| 11:130237036:A:G | L442P | 0.999 |
| 11:130237047:C:A | R438S | 0.999 |
| 11:130237047:C:G | R438S | 0.999 |
| 11:130237048:C:A | R438M | 0.999 |
| 11:130237067:A:G | C432R | 0.999 |
| 11:130237076:A:G | C429R | 0.999 |
| 11:130237080:A:C | F427L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000011780 (11:130303041 T>C,G), RS1000015652 (11:130266536 A>G), RS1000027205 (11:130282642 C>G,T), RS1000083558 (11:130248752 A>G), RS1000148684 (11:130299188 A>G), RS1000167481 (11:130307333 G>A), RS1000201183 (11:130287964 A>AC), RS1000216185 (11:130244951 G>C), RS1000221690 (11:130267265 A>G,T), RS1000265004 (11:130307138 C>T), RS1000321559 (11:130312989 G>T), RS1000330440 (11:130276944 G>A), RS1000433028 (11:130313521 T>C), RS1000475430 (11:130238498 C>T), RS1000504613 (11:130306207 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007094_139 | Diastolic blood pressure | 1.000000e-12 |
| GCST007096_197 | Pulse pressure | 8.000000e-69 |
| GCST007097_21 | Pulse pressure | 3.000000e-21 |
| GCST007097_22 | Pulse pressure | 3.000000e-17 |
| GCST007097_23 | Pulse pressure | 2.000000e-06 |
| GCST007099_69 | Systolic blood pressure | 6.000000e-15 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006336 | diastolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
| EFO:0006335 | systolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5069367 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 6 |
| sodium arsenite | affects methylation, affects cotreatment, decreases expression, increases abundance, increases expression | 3 |
| Arsenic | affects methylation, affects cotreatment, decreases expression, increases abundance, increases expression | 3 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| pinosylvin | decreases expression | 1 |
| avobenzone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression, decreases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression, decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases expression, increases response to substance | 1 |
| jinfukang | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Demecolcine | decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
ChEMBL screening assays
3 unique, capped per target: 3 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5059500 | Binding | Proteomics fold change data (SUDHL4 cells, 1h) | Data for DCP probe CCT369260 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A8A5 | SEES3-1V human ZBTB44, clone1 | Embryonic stem cell | Male |
| CVCL_A8A6 | SEES3-1V human ZBTB44, clone2 | Embryonic stem cell | Male |
| CVCL_A8A7 | SEES3-1V human ZBTB44, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.